Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ventilator mode tested for gentler breathing in ARDS

NCT ID NCT06051188

First seen Jun 22, 2026 · Last updated Jun 22, 2026

Summary

This study tested a new way of delivering breaths from a ventilator (flow-controlled) versus the standard method (pressure-controlled) in 15 adults with moderate to severe acute respiratory distress syndrome (ARDS) in the ICU. The goal was to see if the new method reduces the energy transferred to the lungs, which might cause less damage. Each patient tried both methods for 90 minutes, and the researchers measured lung strain and air distribution.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Erasmus Medical Center

    Rotterdam, 3015 GD, Netherlands

  • Maasstad Hospital

    Rotterdam, South Holland, 3079DZ, Netherlands

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Flow-controlled ventilation (a device that delivers breaths in a controlled flow pattern)

What this could lead to

If it works, this could point toward a gentler way to ventilate ARDS patients, potentially reducing lung damage.

What could go wrong

This is a very small, early study (15 participants) that was terminated, so results are limited. It only looks at short-term effects, not long-term outcomes.

Conditions

The condition(s) this trial relates to.

Respiratory Distress Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.